FIL Ltd lifted its position in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP) by 7.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 730,299 shares of the biopharmaceutical company’s stock after buying an additional 52,929 shares during the quarter. FIL Ltd owned approximately […]
